In line with this, Zafar et al. reported that E2F1 enhanced the expression of kinesin superfamily 26A (KIF26A), abolishing p21 expression, consequently favoring cell cycle progression, resulting in tumor growth in the mouse model of breast cancer (Xu J. et al., 2020). This evidence concerns the gene E2F1 and breast carcinoma.